Targeting IL-17A to combat immune-related adverse events.
Nature cancer
| Authors | |
| Year of Publication | 2024
|
| Journal | Nature cancer
|
| Date Published | 08/2024
|
| ISSN | 2662-1347
|
| DOI | 10.1038/s43018-024-00804-2
|
| PubMed ID | 39210006
|
| Links |